Literature DB >> 21303973

MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model.

Caitlyn W Barrett1, Barbara Fingleton, Amanda Williams, Wei Ning, Melissa A Fischer, Mary K Washington, Rupesh Chaturvedi, Keith T Wilson, Scott W Hiebert, Christopher S Williams.   

Abstract

Myeloid Translocation Gene, Related-1 (MTGR1) CBFA2T2 is a member of the Myeloid Translocation Gene (MTG) family of transcriptional corepressors. The remaining two family members, MTG8 (RUNX1T1) and MTG16 (CBFA2T3) are identified as targets of chromosomal translocations in acute myeloid leukemia (AML). Mtgr1(-/-) mice have defects in intestinal lineage allocation and wound healing. Moreover, these mice show signs of impaired intestinal stem cell function. Based on these phenotypes, we hypothesized that MTGR1 may influence tumorigenesis arising in an inflammatory background. We report that Mtgr1(-/-) mice were protected from tumorigenesis when injected with azoxymethane (AOM) and then subjected to repeated cycles of dextran sodium sulfate (DSS). Tumor cell proliferation was comparable, but Mtgr1(-/-) tumors had significantly higher apoptosis rates. These phenotypes were dependent on epithelial injury, the resultant inflammation, or a combination of both as there was no difference in aberrant crypt foci (ACF) or tumor burden when animals were treated with AOM as the sole agent. Gene expression analysis indicated that Mtgr1(-/-) tumors had significant upregulation of inflammatory networks, and immunohistochemistry (IHC) for immune cell subsets revealed a marked multilineage increase in infiltrates, consisting predominately of CD3(+) and natural killer T (NKT) cells as well as macrophages. Transplantation of wild type (WT) bone marrow into Mtgr1(-/-) mice, and the reciprocal transplant, did not alter the phenotype, ruling out an MTGR1 hematopoietic cell-autonomous mechanism. Our findings indicate that MTGR1 is required for efficient inflammatory carcinogenesis in this model, and implicate its dysfunction in colitis-associated carcinoma. This represents the first report functionally linking MTGR1 to intestinal tumorigenesis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303973      PMCID: PMC3150168          DOI: 10.1158/0008-5472.CAN-10-3317

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.

Authors:  J Andres Martinez; Christopher S Williams; Joseph M Amann; Tiffany C Ellis; Isabel Moreno-Miralles; M Kay Washington; Paul Gregoli; Scott W Hiebert
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

2.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

3.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

4.  The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.

Authors:  W C Powell; B Fingleton; C L Wilson; M Boothby; L M Matrisian
Journal:  Curr Biol       Date:  1999 Dec 16-30       Impact factor: 10.834

5.  Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine.

Authors:  Joseph M Amann; Brenda J Irvin Chyla; Tiffany C Ellis; Andres Martinez; Amy C Moore; Jeffrey L Franklin; Laura McGhee; Shari Meyers; Joyce E Ohm; K Scott Luce; Andre J Ouelette; M Kay Washington; Mary Ann Thompson; Dana King; Shiva Gautam; Robert J Coffey; Robert H Whitehead; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo.

Authors:  Barbara Fingleton; William C Powell; Howard C Crawford; John R Couchman; Lynn M Matrisian
Journal:  Hybridoma (Larchmt)       Date:  2007-02

Review 7.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.

Authors:  B Lutterbach; J J Westendorf; B Linggi; A Patten; M Moniwa; J R Davie; K D Huynh; V J Bardwell; R M Lavinsky; M G Rosenfeld; C Glass; E Seto; S W Hiebert
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728

View more
  25 in total

1.  The transcriptional corepressor MTGR1 regulates intestinal secretory lineage allocation.

Authors:  Bobak Parang; Daniel Rosenblatt; Amanda D Williams; Mary K Washington; Frank Revetta; Sarah P Short; Vishruth K Reddy; Aubrey Hunt; Noah F Shroyer; Michael E Engel; Scott W Hiebert; Christopher S Williams
Journal:  FASEB J       Date:  2014-11-14       Impact factor: 5.191

Review 2.  Cancer in inflammatory bowel disease: lessons from animal models.

Authors:  Daniel A Sussman; Rebeca Santaolalla; Sebastian Strobel; Rishu Dheer; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

3.  Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.

Authors:  Kshipra Singh; Lori A Coburn; Mohammad Asim; Daniel P Barry; Margaret M Allaman; Chanjuan Shi; M Kay Washington; Paula B Luis; Claus Schneider; Alberto G Delgado; M Blanca Piazuelo; John L Cleveland; Alain P Gobert; Keith T Wilson
Journal:  Cancer Res       Date:  2018-05-31       Impact factor: 12.701

4.  AOM/DSS Model of Colitis-Associated Cancer.

Authors:  Bobak Parang; Caitlyn W Barrett; Christopher S Williams
Journal:  Methods Mol Biol       Date:  2016

5.  Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution.

Authors:  T A Kerr; M A Ciorba; H Matsumoto; V R T Davis; J Luo; S Kennedy; Y Xie; A Shaker; B K Dieckgraefe; N O Davidson
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

6.  MTG16 is a tumor suppressor in colitis-associated carcinoma.

Authors:  Elizabeth M McDonough; Caitlyn W Barrett; Bobak Parang; Mukul K Mittal; J Joshua Smith; Amber M Bradley; Yash A Choksi; Lori A Coburn; Sarah P Short; Joshua J Thompson; Baolin Zhang; Shenika V Poindexter; Melissa A Fischer; Xi Chen; Jiang Li; Frank L Revetta; Rishi Naik; M Kay Washington; Michael J Rosen; Scott W Hiebert; Keith T Wilson; Christopher S Williams
Journal:  JCI Insight       Date:  2017-08-17

7.  TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

Authors:  Chaya Levovitz; Dan Chen; Emma Ivansson; Ulf Gyllensten; John P Finnigan; Sara Alshawish; Weijia Zhang; Eric E Schadt; Marshal R Posner; Eric M Genden; Paolo Boffetta; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

8.  Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.

Authors:  Caitlyn W Barrett; Wei Ning; Xi Chen; Jesse Joshua Smith; Mary K Washington; Kristina E Hill; Lori A Coburn; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson; Raymond F Burk; Christopher S Williams
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

9.  Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.

Authors:  Liang Chen; Xiong Yang; Jun Zhao; Ming Xiong; Raya Almaraihah; Zhaohui Chen; Teng Hou
Journal:  J Exp Clin Cancer Res       Date:  2020-05-27

10.  Mapping hyper-susceptibility to colitis-associated colorectal cancer in FVB/NJ mice.

Authors:  Lauren Van Der Kraak; David Langlais; Serge Jothy; Nicole Beauchemin; Philippe Gros
Journal:  Mamm Genome       Date:  2016-03-15       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.